CareLit · DOI-Nachweis · Klinische Pädiatrie
Micafungin – Overview of Safety in Pediatric Patients
DOI 10.1055/s-0030-1261435
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Groll, P Maddison, A Arrieta
ZeitschriftKlinische Pädiatrie
Ausgabe06/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aims: Children at risk of invasive fungal infections are often fragile hosts with multiple underlying conditions. Since drug safety is critical in such patients, we evaluated the safety of micafungin, a novel antifungal agent, by pooling pediatric safety data from clinical trials. Methods: Adverse event (AE) data were pooled from clinical trials conducted in Europe, the Americas and Asia. Results: 296…
Zitieren
Zitierempfehlung
A Groll, P Maddison, A Arrieta (2010) Micafungin – Overview of Safety in Pediatric Patients. Klinische Pädiatrie (06). https://doi.org/10.1055/s-0030-1261435
Mit CareLit weiterarbeiten